BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5454511)

  • 1. [Hemorrhagic diathesis (pseudo hemophilia) due to an specific inhibitor of factor VIII].
    Dreyer MS; Omar Lebas J; Willer de Contardi N; Marti ML; Martinez Canaveri A
    Prensa Med Argent; 1970 Mar; 57(1):21-9. PubMed ID: 5454511
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulopathy associated with factor VIII inhibitor. A literature review.
    Reece EA; Romero R; Hobbins J
    J Reprod Med; 1984 Jan; 29(1):53-8. PubMed ID: 6423820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunocoagulopathies as a possible cause of acquired hemorrhagic diathesis].
    Klare M; Möller T; Hanke P; Weller P; Seige K
    Z Gesamte Inn Med; 1983 May; 38(10):277-80. PubMed ID: 6412468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prothrombin complex concentrates in the treatment of hemorrhage in a non-hemophilic patient with a high factor VIII inhibitor level].
    Tsuji K; Takasugi Y; Kumei Y; Namiki M; Kubota K
    Rinsho Ketsueki; 1987 Jul; 28(7):1187-93. PubMed ID: 3121896
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circulating anticoagulants].
    Krulik M; Debray J; Vergoz D; Yvart J
    Sem Hop; 1971 Jun; 47(28):1820-7. PubMed ID: 4327218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acquired factor VIII inhibitor in non-hemophilic patients].
    Jensen B; Nielsen VG; Karle H
    Ugeskr Laeger; 1976 Apr; 138(17):1031-3. PubMed ID: 1265887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cryptogenic anti-8 inhibitor].
    Rochon M; Neemeh JA; Gosselin G; Long LA
    Union Med Can; 1971 Dec; 100(12):2353-6. PubMed ID: 5163028
    [No Abstract]   [Full Text] [Related]  

  • 8. [Infection, antibiotic therapy and hemorrhagic diathesis].
    Legrand JC; Alewaeters A; Van Cutsem P; Bastin F; Lardinois J
    Rev Med Brux; 1986 Dec; 7(10):618-24. PubMed ID: 3103189
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine.
    Sallah S; Wan JY
    Thromb Haemost; 2001 Oct; 86(4):1119-21. PubMed ID: 11686336
    [No Abstract]   [Full Text] [Related]  

  • 10. Consumption--coagulopathy in Kasabach-Merritt syndrome.
    Rodríguez-Erdmann F; Murray JE; Moloney WC
    Trans Assoc Am Physicians; 1970; 83():168-75. PubMed ID: 5534090
    [No Abstract]   [Full Text] [Related]  

  • 11. [89-year-old woman with hemorrhagic diathesis].
    Seiler T; Goehring P; Spiekermann K
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1933-4. PubMed ID: 19760553
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acquired factor VIII inhibitor in a patient with rheumatoid arthritis].
    Ruiz-Calderón AJ; Carrasco F; Duro R; Constantino M
    Sangre (Barc); 1993 Oct; 38(5):403-5. PubMed ID: 8140505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfusion problems in immunocoagulopathies].
    Lechner K; Stych H
    Bibl Haematol; 1971; 37():199-205. PubMed ID: 5138905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pseudohemophilia due to antihemophilic globulin inhibitor (factor VIII)].
    Procházka J; Podivínský R; Kouril F; Hadam I; Velemínský J
    Vnitr Lek; 1970 Nov; 16(11):1091-103. PubMed ID: 5488288
    [No Abstract]   [Full Text] [Related]  

  • 16. Catastrophic microangiopathy induced by high-titre factor VIII inhibitors after liver transplantation for haemophilia A with cirrhosis.
    Khakhar AK; Chan NG; Allan DS; Chakrabarti S; McAlister VC
    Haemophilia; 2005 Nov; 11(6):623-8. PubMed ID: 16236113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemorrhagic diathesis due to a deficiency of Factor V (pro-accelerine)].
    de Vries SI
    Ned Tijdschr Geneeskd; 1968 Apr; 112(16):741-5. PubMed ID: 5665005
    [No Abstract]   [Full Text] [Related]  

  • 19. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of hemorrhagic diathesis due to disorders during 1st stage of blood clotting].
    Tymiński W; Czestochowska E
    Acta Haematol Pol; 1972; 3(3):265-9. PubMed ID: 4649310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.